Replimune Group, Inc. REPL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.06% | -6.81% | 34.43% | 60.09% | 70.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.69% | 1.14% | 22.50% | 35.56% | 38.62% |
| Operating Income | 15.69% | -1.14% | -22.50% | -35.56% | -38.62% |
| Income Before Tax | 12.33% | -6.37% | -27.41% | -38.44% | -45.71% |
| Income Tax Expenses | -217.74% | -217.74% | -217.74% | -181.96% | 14.71% |
| Earnings from Continuing Operations | 12.64% | -5.99% | -26.95% | -37.95% | -45.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.64% | -5.99% | -26.95% | -37.95% | -45.65% |
| EBIT | 15.69% | -1.14% | -22.50% | -35.56% | -38.62% |
| EBITDA | 16.08% | -1.14% | -23.09% | -37.47% | -40.36% |
| EPS Basic | 19.15% | 2.26% | -10.23% | -11.46% | -13.28% |
| Normalized Basic EPS | 18.84% | 1.89% | -10.64% | -11.82% | -13.33% |
| EPS Diluted | 19.15% | 2.26% | -10.23% | -11.46% | -13.28% |
| Normalized Diluted EPS | 18.84% | 1.89% | -10.64% | -11.82% | -13.33% |
| Average Basic Shares Outstanding | 8.93% | 9.31% | 15.54% | 23.39% | 27.71% |
| Average Diluted Shares Outstanding | 8.93% | 9.31% | 15.54% | 23.39% | 27.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |